Herbal World Female (symbol) Rejuvenator

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

Turnera diffusa, Quantity: 37.5 microgram/mL (Equivalent: Turnera diffusa, Qty 150 microgram/mL; Equivalent: beta-arbutin, Qty 1.05 microgram/mL); Oenothera biennis, Quantity: 25 microgram/mL (Equivalent: Oenothera biennis, Qty 100 microgram/mL); Dioscorea villosa, Quantity: 625 microgram/mL (Equivalent: Dioscorea villosa, Qty 2.5 mg/mL); Malpighia glabra, Quantity: 82.5 microgram/mL (Equivalent: Malpighia glabra, Qty 825 microgram/mL; Equivalent: ascorbic acid, Qty 10 microgram/mL); Matricaria chamomilla, Quantity: 125 microgram/mL (Equivalent: Matricaria chamomilla, Qty 500 microgram/mL)

から入手可能:

Herbal World Pty Ltd

医薬品形態:

Oral Liquid

構図:

Excipient Ingredients: potable water; sodium benzoate; carbon dioxide; sucrose; maltodextrin; citric acid; vanillin; linalool; delta-decalactone; neryl acetate; ethyl propionate; ethyl butyrate; citronellal; anethole; methyl benzoate; Buchu leaf oil; dimethyl anthranilate; propylene glycol; phenethyl alcohol; Mandarin Oil; benzyl acetate; ethyl acetate; ethanol; Orange Oil; phenylacetaldehyde; cis-3-hexen-1-ol; geraniol; trans-2-Hexenol; terpinen-4-ol; limonene; citral; maltol; menthone; ethyl caprate; Petitgrain oil; isoamyl acetate; Davana oil; Rose Oil; linalyl acetate; geranyl acetate; bergamot oil; benzaldehyde; l-menthyl acetate; Orange Flower Oil; ethyl enantate; benzyl alcohol; alpha-phellandrene; isovaleric acid; geranyl butyrate; Lemon Oil Terpeneless; Cinnamon Leaf Oil; piperonal; gamma-decalactone; jasmine absolute; Ginger Oil; terpineol; hexyl acetate; acetic acid; 4-(para-hydroxyphenyl)-2-butanone; decanal; alpha-irone; alpha-terpineol; benzyl benzoate; caprylic aldehyde; butylated hydroxytoluene; nerol; sweet orange oil terpenes and terpenoids; geranyl propionate; gamma-heptalactone; linalyl isobutyrate; ethyl salicylate; 2,6-nonadien-1-ol; dwarf pine-needle oil; ambrette seed oil; methyl anthranilate; dimethyl sulfide; lauryl aldehyde; terpinyl acetate

投与経路:

Oral

クラス:

Medicine Listed

適応症:

Helps reduce/decrease free radical damage to body cells ; Maintain/support cardiovascular system health ; Decrease/reduce/relieve diarrhoea ; Help maintain/support emotional wellbeing ; Decrease/reduce/relieve symptoms of common cold ; Decrease/reduce/relieve cough ; Decrease/reduce/relieve throat irritation

製品概要:

Visual Identification: ;

認証ステータス:

Listed

承認日:

2003-03-28

情報リーフレット

SOLU-CORTEF
®
S
O
L
U
-
C
O
R
T
E
F
®
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1.
WHY AM I BEING TREATED WITH SOLU-CORTEF?
SOLU-CORTEF contains the active ingredient hydrocortisone sodium
succinate. It belongs to a group of medicines called
corticosteroids. SOLU-CORTEF is used to reduce inflammation (pain,
swelling, redness and heat) in certain glandular disorders,
rheumatic disorders, skin diseases, allergic conditions, inflammation
of the eyes, stomach or gut disorders, respiratory diseases and
blood disorders.
For more information, see Section 1. Why am I being treated with
SOLU-CORTEF? in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE TREATMENT WITH SOLU-CORTEF?
Do not use if you have ever had an allergic reaction to hydrocortisone
sodium succinate or any of the ingredients listed at the end of
the CMI.
TALK TO YOUR DOCTOR IF YOU HAVE SEVERE FUNGAL INFECTION, ANY OTHER
MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE
PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING.
For more information, see Section 2. What should I know before
treatment with SOLU-CORTEF? in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines may interfere with SOLU-CORTEF and affect how it works.
A list of these medicines is in Section 3. What if I am taking other
medicines? in the full CMI.
4.
HOW IS SOLU-CORTEF GIVEN?
•
SOLU-CORTEF is given as an injection into a muscle, or slowly into a
vein by a doctor or nurse.
•
Your doctor will decide the dose and frequency of SOLU-CORTEF
depending on your condition.
More instructions for the preparation of solutions for the plain vial
(powder only) or ACT-O-VIAL
®
(powder and diluent) system can
be found in Section 4. How is SOLU-CORTEF given? in the full CMI.
5.
WHAT SHOULD I KNOW DURING TREATMENT WITH SOLU-CORTEF?
THINGS YOU
SHOULD DO
•
If you get an infection or suspect an infection during a course of
treatment, tell your doctor as s

製品の特徴

Version: pfpsoluv11221
Supersedes: pfpsoluv10221
Page 1 of 25
AUSTRALIAN
PRODUCT
INFORMATION
-
SOLU-CORTEF

AND
SOLU-CORTEF
®
ACT-O-
VIAL (HYDROCORTISONE SODIUM SUCCINATE)
1. NAME OF THE MEDICINE
Hydrocortisone sodium succinate
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each SOLU-CORTEF 100 mg plain
vials contains hydrocortisone sodium succinate equivalent
to 100 mg hydrocortisone.
ACT-O-VIAL
®
System Two-Compartment Vial, in three strengths:
100 mg ACT-O-VIAL System: Each 2 mL (when mixed) contains
hydrocortisone sodium
succinate equivalent to 100 mg hydrocortisone.
250 mg ACT-O-VIAL System: Each 2 mL (when mixed) contains
hydrocortisone sodium
succinate equivalent to 250 mg hydrocortisone.
500 mg ACT-O-VIAL System: Each 4 mL (when mixed) contains
hydrocortisone sodium
succinate equivalent to 500 mg hydrocortisone.
For the full list of excipients, see section 6.1, List of excipients.
3. PHARMACEUTICAL FORM
SOLU-CORTEF powder for injection: White freeze dried cake
SOLU-CORTEF ACT-O-VIAL is available in dual chamber vials consisting
of powder for
injection and diluent.
Powder for injection: White freeze dried cake.
Diluent: Clear colourless liquid.
4. CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
When oral therapy is not feasible, and the strength, form and route of
administration of the drug
reasonably lend the preparation to the treatment of the condition,
SOLU-CORTEF powder for
injection is indicated for intravenous or intramuscular use in the
following conditions:
1.
ENDOCRINE DISORDERS
•
Primary or secondary adrenocortical insufficiency (hydrocortisone or
cortisone is
the
drug
of
choice;
synthetic
analogues
may
be
used
in
conjunction
with
mineralocorticoids
where
applicable;
in
infancy,
mineralocorticoid
Version: pfpsoluv11221
Supersedes: pfpsoluv10221
Page 2 of 25
supplementation is of particular importance). Acute adrenocortical
insufficiency
(hydrocortisone or cortisone is the drug of choice; mineralocorticoid
supplements
may be necessary, particularly when synthetic analogues are used).
•
Pre